Is tamoxifen good enough for the Asian population in ER+ HER2- post-menopausal women with early breast cancer? A nationwide population-based cohort study.

Is tamoxifen good enough for the Asian population in ER+ HER2- post-menopausal women with early breast cancer? A nationwide population-based cohort study.

<h4>Background</h4>Numerous clinical trials have compared the efficacy of endocrine therapy in post-menopausal breast cancer patients. This study aims to explore whether there is a difference in recurrence rates between this population using tamoxifen and aromatase inhibitors (AIs) by an...

Full description

Saved in:
Bibliographic Details
Main Authors: Chuan-Hsun Chang, Yi-Chan Lee, Chun-Wen Huang, You-Min Lu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0313120
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items